Apr 3, 2020| JD Health

Wall Street Journal Highlights JD Health’s Online Consultation

Tracy Yang

by Tracy Yang

An article entitled “Telemedicine, once a hard sell, can’t keep up with demand” was published by the Wall Street Journal yesterday. The article discussed the huge demand generated from COVID-19 for telemedicine and how various companies in the world, like Teladoc, Doctor on Demand and others tried their best to add doctors and bandwidth to meet the demand from users.

JD Health’s initiative to launch the online consulting services to connect Chinese doctors with 60 million overseas Chinese was highlighted in the article. It also mentioned that the doctors on the platform have first-hand experience in combating the coronavirus.

In JD Health’s eyes, the pandemic has sped up the adoption of telemedicine by Chinese consumers by five years. The article also mentioned that the telemedicine industry faces challenges such as government regulation, insurance and reimbursements and patients’ trust.

(tracy.yang@jd.com)

Sep 9, 2022| JD Health

JD Health’s “Pharmacy Clinic” Awarded at CIFTIS

Vivian Yang

by Vivian Yang

JD Health’s online pharmaceutical consulting service was awarded as an excellent demonstration case in China’s service industry by the committee of the China International Fair for Trade in Services (CIFTIS) on September 5^th in Beijing.

JD Health launched the service, known as the “Pharmacy Clinic,” in June 2022. The service connects licensed pharmacists with clinic experiences to patients through the internet. Based on each patient’s condition, pharmacists provide medicine evaluation and customized adjustment plans, follow up with their medicine use, offer pharmaceutical advice and more, hence providing patients with a one-stop medication service solution outside of offline doctor’s visits.

The National Medical Products Administration issued supervision and management measures on online sales of medicines on the same day, September 5, which stated specific requirements on ensuring the safety of online medicine sales, among which Article 10 clearly says that enterprises engaged in online sales of medicines shall establish a pharmaceutical care system, and carry out prescription examination and guidance on rational use of medicines and other services from certified pharmacists and other pharmaceutical technicians to consumers. JD Health’s “Pharmacy Clinic” has undoubtedly taken action a step ahead of the new rules from the government.

Currently, more than 2,000 certified pharmacists are providing online pharmaceutical consulting services on JD Health. Such service will continue to be integrated with JD Health’s other online services including its internet hospitals, JD Pharmacy’s single-disease care centers and more, building a better user experience in post-diagnosis medicine use management and home-based pharmaceutical services.

(vivian.yang@jd.com)

Aug 29, 2022| Financial, JD Health

JD Health Interim Financial Report: Focus on Two-Wheels-Driven Growth

Vivian Yang

by Vivian Yang

JD Health announced its interim results for the six months that ended June 30^th, 2022 on August 23^rd, which beat both topline and bottom line expectations. Highlights in numbers include:

Net revenue of RMB 20.2 billion yuan, an increase of 48.3 percent YoY;
Non-IFRS net income of RMB 1.21 billion yuan, up by 82.0 percent YoY;
Annual active user accounts reached 131.3 million, representing a YoY net increase of 22.7 million;
The number of warehouses increased to 20 medicine warehouses and over 450 non-medicine ones;
JD Pharmacy’s self-operated cold-chain fulfillment operation covered more than 240 cities across China, and offline Direct-to-Patient (DTP) drug stores extended to 26 provincial-level administrative regions;
The average online healthcare consultation volume exceeded 250,000 per day;
27 online specialized medical centers have been established.

According to the report, during the reporting period, merchandise sales accounted for over 80 percent of net revenues, while that of services contributed nearly 15 percent. Despite this disparity, Enlin Jin, CEO of JD Health reaffirmed the company’s “two-wheels-driven” approach that focuses on both product supply chain and services.

While the “left-wheel” of online retail is generating stronger growth momentum now, JD Health is and must gradually pivot to the “right wheel” of service offerings, especially online healthcare services for greater and long-term development, Jin noted.

This June, JD Health upgraded its medical services and launched three new online consultation services: “Expert Consulting”, “Instant Consultation with JD Doctor” and “Nighttime Consultation” to further address users’ diverse needs. The “Expert Consulting” service cooperates with leading physicians from multiple “3A” (the top tier) hospitals in China; the “Nighttime Consultation” service arranges on-duty doctors to provide consultation services available overnight; and the “Instant Consultation with JD Doctor” service provides users with standardized medical consultation services through carefully selected in-house and external physicians.

In addition, JD Health released its “Enterprise Health Strategy” in June, offering corporate clients a full range of customized online and offline employee health management and medical services, covering multiple solutions including corporate emergency rescue management, employee weight and mental health management.

In the meantime, JD Health is leveraging its technological capabilities to empower medical institutions on digital transformation including operation models, supply chain management, healthcare service upgrading and more.

(vivian.yang@jd.com)